Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pigeon

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|April 15, 2005
Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behaviorPascal Pigeon, Siden Top, Anne Vessières, et al.
Molecules (Basel, Switzerland)|July 19, 2014
Atypical McMurry cross-coupling reactions leading to a new series of potent antiproliferative compounds bearing the key [ferrocenyl-ene-phenol] motifPascal Pigeon, Meral Görmen, Konrad Kowalski, et al.
International Journal of Pharmaceutics|September 11, 2022
Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinomaPierre Idlas, Abdallah Ladaycia, Fariba Némati, et al.
Chemical Science|April 10, 2018
A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative propertiesYong Wang, Patrick M Dansette, Pascal Pigeon, et al.
Dalton Transactions (Cambridge, England : 2003)|June 9, 2016
The length of the bridging chain in ansa-metallocenes influences their antiproliferative activity against triple negative breast cancer cells (TNBC)Matthieu Beauperin, Siden Top, Marie-Aude Richard, et al.
European Journal of Medicinal Chemistry|March 13, 2022
Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cellsYong Wang, Pascal Pigeon, Wei Li, et al.
Drug Delivery and Translational Research|January 7, 2026
Self-assemblies from prodrugs composed of antimicrobial peptides: a revolution in local lung cancer treatment, with microbiota as a main actorAbdallah Ladaycia, Laurent Lemaire, Hélène Pailhoriès, et al.
International Journal of Molecular Sciences|October 13, 2021
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic SubtypesAnne Vessières, Emie Quissac, Nolwenn Lemaire, et al.
Angewandte Chemie (International Ed. in English)|June 9, 2016
Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative TransformationYong Wang, Marie-Aude Richard, Siden Top, et al.
Angewandte Chemie (International Ed. in English)|April 13, 2019
Atypical Lone Pair-π Interaction with Quinone Methides in a Series of Imido-Ferrociphenol Anticancer Drug CandidatesYong Wang, Pascal Pigeon, Siden Top, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|April 15, 2005
Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behaviorPascal Pigeon, Siden Top, Anne Vessières, et al.
Molecules (Basel, Switzerland)|July 19, 2014
Atypical McMurry cross-coupling reactions leading to a new series of potent antiproliferative compounds bearing the key [ferrocenyl-ene-phenol] motifPascal Pigeon, Meral Görmen, Konrad Kowalski, et al.
International Journal of Pharmaceutics|September 11, 2022
Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinomaPierre Idlas, Abdallah Ladaycia, Fariba Némati, et al.
Chemical Science|April 10, 2018
A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative propertiesYong Wang, Patrick M Dansette, Pascal Pigeon, et al.
Dalton Transactions (Cambridge, England : 2003)|June 9, 2016
The length of the bridging chain in ansa-metallocenes influences their antiproliferative activity against triple negative breast cancer cells (TNBC)Matthieu Beauperin, Siden Top, Marie-Aude Richard, et al.
European Journal of Medicinal Chemistry|March 13, 2022
Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cellsYong Wang, Pascal Pigeon, Wei Li, et al.
Drug Delivery and Translational Research|January 7, 2026
Self-assemblies from prodrugs composed of antimicrobial peptides: a revolution in local lung cancer treatment, with microbiota as a main actorAbdallah Ladaycia, Laurent Lemaire, Hélène Pailhoriès, et al.
International Journal of Molecular Sciences|October 13, 2021
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic SubtypesAnne Vessières, Emie Quissac, Nolwenn Lemaire, et al.
Angewandte Chemie (International Ed. in English)|June 9, 2016
Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative TransformationYong Wang, Marie-Aude Richard, Siden Top, et al.
Angewandte Chemie (International Ed. in English)|April 13, 2019
Atypical Lone Pair-π Interaction with Quinone Methides in a Series of Imido-Ferrociphenol Anticancer Drug CandidatesYong Wang, Pascal Pigeon, Siden Top, et al.
Pageof 5